Skip to content
Open access

The Role of Artificial Intelligence in Modern Biomedical Research: From Data to Drugs

Jul 2026 · Applied and Computational Engineering · Vol 252, pp. 50-54 · 0 citations

TL;DR

The value of artificial intelligence in three biomedical domains is summarized: multi-omics data integration for disease prediction, medical image analysis for clinical diagnose and drug discovery and future research should build more stable and interpretable models.

Abstract

The ability to efficiently analyze large-scale and complex biological data helps artificial intelligence to rapidly revolutionize biomedical research. This paper summarizes the value of artificial intelligence in three biomedical domains: multi-omics data integration for disease prediction, medical image analysis for clinical diagnose and drug discovery. In multi-omics research, artificial intelligence optimizes integration outcomes of heterogeneous biological datasets, deepening cognition of disease mechanisms and polishing predictive models. In medical imaging, deep learning performs excellently in various diagnosis tasks, yet the lack of interpretability brings out limitations. To address the problem, explainable artificial intelligence was generated to effectively increase model transparency and clinical validation. In drug discovery, artificial intelligence significantly accelerates main processes, including virtual screening, drug repurposing and protein structure prediction. In particular, AlphaFold is one of the most paramount breakthroughs. Despite these advancements, data heterogeneity, lack of clinical validation samples and model interpretability shortage restrain the practical usage of relevant techniques. This paper sorts out the potential and limitations of artificial intelligence in biomedical research, pointing out that future research should build more stable and interpretable models.

Read PDF

Similar papers

Review Open access Aug 2026

ARTIFICIAL INTELLIGENCE IN MODERN MEDICINE: A COMPREHENSIVE REVIEW OF CURRENT APPLICATIONS, CHALLENGES, AND FUTURE PERSPECTIVES

This review evaluates the current state of AI applications in medicine, focusing on clinical knowledge encoding, molecular drug discovery, and administrative workflow optimization, while critically addressing the technical, ethical, and systemic challenges of their institutional implementation.

Aleksandra Stańczyk, Kinga Haduch, Zuzanna Michalska et al. · 0 citations
Review Open access Sep 2026

Artificial Intelligence in Modern Biology: Transforming Research and Healthcare

Artificial Intelligence (AI) has emerged as a transformative force in biological sciences and healthcare, fundamentally reshaping research methodologies, data analysis, disease diagnosis, drug discovery, and personalized medicine. The rapid advancement of high-throughput biological technologies has generated unpreceden...

Neha Agarwal, Neetu Singh · 0 citations
Review Open access Aug 2026

Artificial Intelligence in Life Sciences: Machine Learning Approaches for Disease Prediction, Biomarker Discovery, and Personalized Healthcare

Artificial intelligence (AI), particularly machine learning (ML), is reshaping life sciences by enabling the analysis of complex biological and clinical data for disease prediction, biomarker discovery, and personalized healthcare. However, existing research remains fragmented across individual applications, while conc...

Sidra Saeed, Sadia Shahbaz, Sadia Zahid · 0 citations
Review Open access Aug 2026

Research Progress in Network Medicine and Artificial Intelligence-Based Prediction of Drug Combination Synergy

Current studies remain constrained by data sparsity, negative-sample bias, insufficient model interpretability and limited prospective validation, so future work should strengthen standardized data integration, mechanism-constrained modeling and joint dose-timing optimization to improve interpretability, generalizabili...

Haoyang Su · 0 citations
Review Open access Aug 2026

A survey of LLMs in drug discovery and precision medicine

This comprehensive review examines the state-of-the-art applications of LLMs across the drug development pipeline, spanning target identification, molecular generation, property prediction, and drug repurposing in drug discovery, as well as clinical decision support, patient stratification, treatment personalization, a...

Hasi Hays, William J. Richardson · 2 citations
Review Open access Sep 2026

A Review on Artificial Intelligence & Machine Learning Are Used for Drug Discovery in Prostate Cancer

Artificial intelligence (AI) and Machine learning are transforming drug discovery in prostate cancer by addressing the biological heterogeneity, therapeutic resistance, and inefficiencies inherent in traditional pipelines. By integrating multi-omics, imaging, and clinical datasets, Artificial intelligence/Machine learn...

A. Musa, Muhammad Lawan Wasaram, Kashim Ibrahim Muhammad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.